SCHEMBL32676010

SCHEMBL32676010

Cc1noc(C)c1COc1cccc(C(=O)NNC(=O)c2ccc(C(F)(F)F)cn2)c1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
LMNA P02545 5/20 0.58
HPGD P15428 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
MAPT P10636 3/20 0.58
TSHR P16473 4/20 0.58
ATM Q13315 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
ALOX15 P16050 2/20 0.57
HSD17B10 Q99714 1/20 0.56
RAC1 P63000 1/20 0.53
RAB9A P51151 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.51
POLB P06746 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
KDM4E B2RXH2 1/20 0.51
KMT2A Q03164 1/20 0.51
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30835860 0.85 ALDH1A1 (0.56) ALDH1A1LMNAHPGDSMN1; SMN2MAPT
SCHEMBL32676011 0.84 ALDH1A1 (0.65) ALDH1A1LMNAHPGDSMN1; SMN2MAPT
SCHEMBL32676006 0.80 ALDH1A1 (0.63) ALDH1A1LMNAHPGDSMN1; SMN2MAPT
SCHEMBL32676009 0.79 ALDH1A1 (0.70) ALDH1A1LMNAHPGDSMN1; SMN2MAPT
SCHEMBL28915156 0.76 ALDH1A1 (0.72) ALDH1A1LMNAHPGDSMN1; SMN2MAPT
SCHEMBL30165933 0.76 GAA (0.72) ALDH1A1LMNAHPGDSMN1; SMN2MAPT
SCHEMBL28588209 0.76 GAA (0.72) ALDH1A1LMNAHPGDSMN1; SMN2MAPT
SCHEMBL31217534 0.75 ALDH1A1 (0.70) ALDH1A1LMNAHPGDSMN1; SMN2MAPT
SCHEMBL17109041 0.74 LMNA (0.77) ALDH1A1LMNAHPGDSMN1; SMN2MAPT
SCHEMBL38660523 0.74 LMNA (0.78) ALDH1A1LMNAHPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049064-A1 PROTEIN:PROTEIN INTERACTION INHIBITORS PURDUE RESEARCH FOUNDATION (US) 2026-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049064-A1 PROTEIN:PROTEIN INTERACTION INHIBITORS PRMT6, PRMT5, PRMT1 ALDH1A1 4797/4885LMNA 1656/4885HPGD 4323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.